Clinical Trial Update: Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial update for orismilast in mild to severe hidradenitis suppurativa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Orismilast (orismilast)

Snippet

Sponsor: Gregor Jemec | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: UNKNOWN